These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 30268050)

  • 21. Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.
    Lee JH; El-Damasy AK; Seo SH; Gadhe CG; Pae AN; Jeong N; Hong SS; Keum G
    Bioorg Med Chem; 2018 Nov; 26(21):5596-5611. PubMed ID: 30385226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 5-substituted-2-anilinoquinolines with 3-(morpholino or 4-methylpiperazin-1-yl)propoxy moiety as broad spectrum antiproliferative agents: Synthesis, cell based assays and kinase screening.
    El-Damasy AK; Cho NC; Pae AN; Kim EE; Keum G
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3307-3312. PubMed ID: 27241691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38αMAPK and ERK1/2 inhibitory activity.
    Awadallah FM; Abou-Seri SM; Abdulla MM; Georgey HH
    Eur J Med Chem; 2015 Apr; 94():397-404. PubMed ID: 25778995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives.
    El-Ansary SL; Hussein MM; Abdel Rahman DE; Abdel Ghany LM
    Bioorg Chem; 2014 Apr; 53():50-66. PubMed ID: 24607350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
    Abouzid KAM; Al-Ansary GH; El-Naggar AM
    Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors.
    Amr AEE; Abo-Ghalia MH; Moustafa GO; Al-Omar MA; Nossier ES; Elsayed EA
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30241374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study on MAPK/ERK and CDK2-Cyclin-E signal switch "on and off" in cell proliferation by bis urea derivatives of 1, 4-Diisocyanatobenzene.
    Nagalakshmamma V; Venkataswamy M; Pasala C; Uma Maheswari A; Thyaga Raju K; Nagaraju C; Chalapathi PV
    Bioorg Chem; 2021 Jul; 112():104940. PubMed ID: 33965780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
    El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
    Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and anticancer activity of naphthoquinone derivatives.
    Shen XB; Wang Y; Han XZ; Sheng LQ; Wu FF; Liu X
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):773-785. PubMed ID: 32200656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
    da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
    Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules.
    Defant A; Mancini I
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31197105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors.
    Bhuva HA; Kini SG
    J Mol Graph Model; 2010 Aug; 29(1):32-7. PubMed ID: 20493747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
    Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
    Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors.
    Mowafy S; Farag NA; Abouzid KA
    Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
    Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, Biological Evaluation, and Antioxidant and Cytotoxic Activity of Heteroatom-Substituted 1,4-Naphtho- and Benzoquinones.
    Deniz NG; Ibis C; Gokmen Z; Stasevych M; Novikov V; Komarovska-Porokhnyavets O; Ozyurek M; Guclu K; Karakas D; Ulukaya E
    Chem Pharm Bull (Tokyo); 2015; 63(12):1029-39. PubMed ID: 26633024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers.
    El-Sharief AMS; Ammar YA; Belal A; El-Sharief MAMS; Mohamed YA; Mehany ABM; Elhag Ali GAM; Ragab A
    Bioorg Chem; 2019 Apr; 85():399-412. PubMed ID: 30665034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of synthesized 1,4-naphthoquinone analogues on selected human cancer cell lines.
    Kishore N; Binneman B; Mahapatra A; van de Venter M; du Plessis-Stoman D; Boukes G; Houghton P; Marion Meyer JJ; Lall N
    Bioorg Med Chem; 2014 Sep; 22(17):5013-9. PubMed ID: 25059501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer properties of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives; kinase inhibitors.
    Rezaei Z; Mahdi Didehvar M; Mahdavi M; Azizian H; Hamedifar H; Mohammed EHM; Ostad S; Amini M
    Bioorg Chem; 2019 Sep; 90():103055. PubMed ID: 31220669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors.
    El-Wakil MH; Ashour HM; Saudi MN; Hassan AM; Labouta IM
    Bioorg Chem; 2017 Aug; 73():154-169. PubMed ID: 28715754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.